Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2019-09-26 to 2024-02-29
Current total value of award: $6859876.72
Description: ANALGESIC KETAMINE-CLINICAL TRIAL